SELLAS Life Sciences Group, Inc. (SLS)
2.835
+0.06
(+2.35%)
USD |
NASDAQ |
Dec 24, 12:59
2.87
+0.04
(+1.23%)
After-Hours: 13:59
SELLAS Life Sciences Group SG&A Expense (TTM): 11.21M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Geron Corp. | 160.96M |
| GT Biopharma, Inc. | 6.564M |
| ADMA Biologics, Inc. | 96.37M |
| NovaBay Pharmaceuticals, Inc. | 8.584M |
| Palatin Technologies, Inc. | 7.449M |